References
- Suda T. Up-to-date information on rheumatoid arthritis-associated interstitial lung disease. Clin Med Insights Circ Respir Pulm Med. 2016;31(9):155–162.
- Okada H, Kurasawa K, Yamazaki R, et al. Clinical features of organizing pneumonia associated with rheumatoid arthritis. Mod Rheumatol. 2016;26(6):863–868.
- Huang Y, Lin W, Chen Z, et al. Effect of tumor necrosis factor inhibitors on interstitial lung disease in rheumatoid arthritis: angel or demon? Drug Des Devel Ther. 2019;13:2111–2125.
- Sakaida H, Komase Y, Takemura T. Organizing pneumonia in a patient with rheumatoid arthritis treated with etanercept. Mod Rheumatol. 2010;20(6):611–616.
- Gouveia P, Ferreira E, Neto P. Organizing pneumonia induced by tocilizumab in a patient with rheumatoid arthritis. Cureus. 2020;12(2):e6982.
- Soubrier M, Jeannin G, Kemeny JL, et al. Organizing pneumonia after rituximab therapy: two cases. Joint Bone Spine. 2008;75(3):362–365.
- Rice JB, White AG, Scarpati LM, et al. Long-term systemic corticosteroid exposure: a systemic literature review. Clin Ther . 2017;39(11):2216–2229.
- Kondoh Y, Taki F, Ando M, et al. A case of bronshiolitis obliterans organizing pneumonia in a patient with rheumatoid arthritis who responded to corticosteroid and immunosuppressant therapy. Nihon Kyobu Shikkan Gakkai Zasshi. 1992;30(6):1165–1170.
- Pommepuy I, Farny M, Billey T, et al. Bronchiolitis obliterans organizing pneumonia in a patient with rheumatoid arthritis. Rev Rheum Engl Ed. 1998;65(1):65–67.
- Kaushik P, Cooper ES, Banda VR, et al. Bronchiolitis obliterans with organizing pneumonia in rheumatoid arthritis-a fatal case and short review of literature. Rheumatol Int. 2005;25(5):391–393.
- Cohen AJ, King TE, Downey GP. Rapidly progressive bronchiolitis obliterans with organizing pneumonia. Am J Respir Crit Care Med. 1994;149(6):1670–1675.
- Hodge JA, Kawabata TT, Krishnaswami S, et al. The mechanism of action of tofacitinib-an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. Clin Exp Rheumatol. 2016;34(2):318–328.
- Mori S, Koga Y, Sugimoto M. Organizing pneumonia in rheumatoid arthritis patients: a case-based review. Clin Med Insights Circ Respir Pulm Med. 2015;9(Suppl 1):69–80.
- Kurasawa K, Arai S, Namiki Y, et al. Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis. Rheumatology (Oxford). 2018;57(12):2114–2193.
- Chen Z, Wang X, Ye S. Tofacitinib in amyopathic dermatomyositis-associated interstitial lung disease. N Engl J Med. 2019;381(3):291–293.
- Glaspole IN, Hoy RF, Ryan PF. A case of certolizumab-induced interstitial lung disease in a patient with rheumatoid arthritis. Rheumatology (Oxford). 2013;52(12):2302–2304.
- Kawasumi H, Gono T, Tanaka E, et al. Clinical Characteristics and cytokine profiles of organizing pneumonia in patients with rheumatoid arthritis treated with or without biologics. J Rheumatol. 2016;43(4):738–744.
- Epler GR. Drug-induced bronchiolitis obliterans organizing pneumonia. Clin Chest Med. 2004;25(1):89–94.